CARCINOMA, BRONCHOGENIC
Clinical trials for CARCINOMA, BRONCHOGENIC explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, BRONCHOGENIC trials appear
Sign up with your email to follow new studies for CARCINOMA, BRONCHOGENIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Real-World test for advanced lung cancer treatment combo
Disease control OngoingThis study is observing how well a combination of the drug Osimertinib and standard chemotherapy works for people with a specific type of advanced lung cancer (EGFR-positive NSCLC) in a real-world setting. It involves 532 adult patients who have already started this specific trea…
Matched conditions: CARCINOMA, BRONCHOGENIC
Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Can better doctor training save more lung cancer patients?
Knowledge-focused OngoingThis study aims to see if providing standardized training to cancer doctors in smaller city and county hospitals leads to better testing and treatment for patients with advanced non-small cell lung cancer. It will follow 1,000 patients to measure if doctors order more recommended…
Matched conditions: CARCINOMA, BRONCHOGENIC
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC